Targeting microglial EP4 receptor activation to treat multiple sclerosis
A therapeutic approach that activates the prostaglandin PGE2 receptor EP4 on microglia to enhance phagocytosis and promote myelin debris clearance, offering a novel avenue for treating multiple sclerosis and related demy...